Your browser doesn't support javascript.
Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.
van de Veerdonk, Frank L; Kouijzer, Ilse J E; de Nooijer, Aline H; van der Hoeven, Hans G; Maas, Coen; Netea, Mihai G; Brüggemann, Roger J M.
  • van de Veerdonk FL; Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.
  • Kouijzer IJE; Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.
  • de Nooijer AH; Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.
  • van der Hoeven HG; Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.
  • Maas C; Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.
  • Netea MG; Department of Intensive Care Medicine, Radboudumc, Nijmegen, the Netherlands.
  • Brüggemann RJM; Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
JAMA Netw Open ; 3(8): e2017708, 2020 08 03.
Article in English | MEDLINE | ID: covidwho-712538

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Bradykinin / Coronavirus Infections / Receptor, Bradykinin B2 / Bradykinin B2 Receptor Antagonists Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: JAMA Netw Open Year: 2020 Document Type: Article Affiliation country: Jamanetworkopen.2020.17708

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Bradykinin / Coronavirus Infections / Receptor, Bradykinin B2 / Bradykinin B2 Receptor Antagonists Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: JAMA Netw Open Year: 2020 Document Type: Article Affiliation country: Jamanetworkopen.2020.17708